Brain tumor zapped with laser, then supercharged immune system fights back
NCT ID NCT03277638
Summary
This study is testing a two-part treatment for adults whose aggressive brain cancer (glioblastoma) has returned. First, surgeons use a laser to precisely heat and destroy the tumor. Then, patients receive an immunotherapy drug (pembrolizumab) designed to help their own immune system find and attack any remaining cancer cells. The main goals are to find the safest timing for this combination and to see how well it works at controlling the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.